| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 10/07/2008 | US7432271 Atherosclerosis; anticholesterol agents; cardiovascular disorders; stroke; thrombosis; hypotensive agents; restenosis; antidiabetic agents; antiarthritic agents; anticancer agnets; inflammatory bowel disorders |
| 10/07/2008 | US7432266 Phosphodiesterase 4 inhibitors |
| 10/07/2008 | US7432225 Synergistic mixture containing cloquintocet-mexyl |
| 10/07/2008 | US7432058 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor; |
| 10/07/2008 | CA2369753C (s)-enantiomer enriched fipronil composition |
| 10/07/2008 | CA2362831C Thioamide derivatives |
| 10/02/2008 | WO2008116663A2 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments |
| 10/02/2008 | WO2008116602A1 Cosmetic preparations designed to reduce unsightly cellulite |
| 10/02/2008 | WO2008099076A3 Substituted n-(4-cyano-1h-pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereof |
| 10/02/2008 | WO2008075068A3 Acylaminopyrazoles as fgfr inhibitors |
| 10/02/2008 | WO2007121339A3 Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (vr1) receptors |
| 10/02/2008 | US20080242656 N-Substituted-N-Sulfonylaminocyclopropane Compounds and Pharmaceutical Use Thereof |
| 10/02/2008 | CA2682163A1 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments |
| 10/02/2008 | CA2682039A1 Cosmetic preparations designed to reduce unsightly cellulite |
| 10/01/2008 | EP1975620A2 Three hybrid assay system |
| 10/01/2008 | EP1975161A1 Heterocyclyl-substituted- tetrahydro-napthalen-amine derivatives, their preparation and use as medicaments |
| 10/01/2008 | EP1975157A1 METHOD FOR PRODUCTION OF HETEROAROMATIC RING COMPOUND HAVING N-Rf GROUP |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | CN101277939A Acyclic ikur inhibitors |
| 10/01/2008 | CN101277938A Process for the production of amides |
| 10/01/2008 | CN101274926A Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 10/01/2008 | CN100422171C Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 10/01/2008 | CN100422141C Method for producing 2-dihaloacyl-3-amino-acrylic acid esters and 3-dihalomethyl-pyrazole-4-carboxylic acid esters |
| 09/30/2008 | US7429609 Pyrazole compound and medicinal composition containing the same |
| 09/30/2008 | US7429603 C-fms kinase inhibitors |
| 09/30/2008 | US7429591 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(2-Amino-6-chloro-phenyl)-piperazin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 09/30/2008 | US7429278 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers |
| 09/30/2008 | CA2382480C Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 09/25/2008 | WO2008115705A2 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 09/25/2008 | WO2008114812A1 Jak inhibitor |
| 09/25/2008 | WO2008114622A1 Oxidative color-developing compounds, salts thereof, process for production of the same, reagent compositions and test tools made by using the same |
| 09/25/2008 | WO2008113795A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/25/2008 | WO2008113760A2 Arylsulphonyglycine derivatives as suppressors of the interaction of glycogen phosphorylase a with the gl subunit of glycogen-associated protein phosphatase 1 (ppl) for the treatment of metabolic disorders, particulary diabetes |
| 09/25/2008 | WO2008060391A3 2- [l-phenyl-5-hydr0xy-4alpha-methyl-hexahydr0cycl0penta[f] indaz0l-5-yl] ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 09/25/2008 | US20080234491 Process for preparation of celecoxib |
| 09/25/2008 | US20080234350 Controlling phytopathogenic fungi for crop protection |
| 09/25/2008 | US20080234348 3-Oxoindazolesquaric Acid Derivatives |
| 09/25/2008 | US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 09/25/2008 | US20080234293 Tri-aryl/heteroaromatic cannabinoids and use thereof |
| 09/25/2008 | US20080234281 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer |
| 09/25/2008 | US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk) |
| 09/25/2008 | US20080234268 Effective for prophylaxis and treatment of diseases, such as ("c-Met") hepatocyte growth factor receptor mediated diseases; N-(4-(3-amino-1H-indazol-4-yl)-3-fluorophenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide; treatment of neoplasia selected from lung, breast, colon cancer |
| 09/25/2008 | US20080234266 Squaric Acid Derivatives II |
| 09/25/2008 | US20080234259 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant |
| 09/25/2008 | US20080234199 Chemical Compounds |
| 09/25/2008 | CA2681124A1 New substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 09/24/2008 | EP1971602A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 09/24/2008 | CN101273048A Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 09/24/2008 | CN101270092A Method for synthesizing neotame |
| 09/24/2008 | CN100420672C Selective COX-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 09/23/2008 | US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/23/2008 | CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof |
| 09/18/2008 | WO2008111473A1 Glucokinase activator |
| 09/18/2008 | WO2008110846A2 Compositions comprising (s)-2-amino-1-(4-chlorophenyl)-1-[4-(1h-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases |
| 09/18/2008 | WO2008110698A2 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof |
| 09/18/2008 | WO2008110566A1 Compounds which potentiate ampa receptor and uses thereof in medicine |
| 09/18/2008 | WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | WO2008092816A3 Novel polymorphic forms of n-piperidino-5-(4-chlorophenyl)-1(2, 4-dichlorphenyl)-4-methyl-3-pyrazolecarboxamide |
| 09/18/2008 | WO2008088900A9 Polymorphic forms of rimonabant base and processes for preparation thereof |
| 09/18/2008 | US20080227840 Bicyclic 5-Hydroxypyrazolines, Method For Producing the Same and Agents Comprising the Same |
| 09/18/2008 | US20080227821 N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors |
| 09/18/2008 | US20080227820 cis-6-Fluoro-1-{[1-(4-fluorophenyl)-1H-indazol-4-yl]amino}-1,2,3,4-tetrahydro-5-methoxy-4,4-dimethyl-6-(trifluoromethyl)naphthalene-2-ol; selectivity towards the glucocorticoid receptor (GR) is improved compared to the other steroid receptors |
| 09/18/2008 | US20080227787 4-tert-Butyl-N'-(2-(hydroxyimino)-1-phenylethylidene)benzohydrazide; treatment of inflammation |
| 09/18/2008 | CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer |
| 09/18/2008 | CA2679971A1 Glucokinase activator |
| 09/18/2008 | CA2679878A1 Pharmaceutical compounds |
| 09/18/2008 | CA2677295A1 Method for preparing fluorinated sulphanylamides and sulphinamidines and uses thereof |
| 09/17/2008 | EP1968935A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments |
| 09/17/2008 | EP1968578A2 POLYMORPHS AND AMORPHOUS FORMS OF 5-AMINO-l-[2,6- DICHLORO-4-(TRIFLUOROMETHYL)PHENYL]-4- [(TRIFLUOROMETHYL)SULFINYL]-IH-PYRAZOLE-3-CARBONITRILE |
| 09/17/2008 | EP1968577A2 Targeting gli proteins in human cancer by small molecules |
| 09/17/2008 | EP1856054B1 Pyrazolylcarboxanilides |
| 09/17/2008 | EP1828164B1 Method for preparing n-phenylpyrazole-1-carboxamides |
| 09/17/2008 | EP1791825B1 Benzoyl-substituted serine amides |
| 09/17/2008 | EP1447400B1 Bicyclic compound |
| 09/17/2008 | CN101268056A Process for preparing 4-aminopyrazole derivative |
| 09/17/2008 | CN101268055A Method for the production of 5-fluoro-1,3-dialkyl-1h-pyrazole-4-carbonyl fluorides |
| 09/17/2008 | CN100418952C Biphenyl derivatives and their use as fungicides |
| 09/17/2008 | CN100418951C Cycloamine derivative and its use as medicine |
| 09/16/2008 | US7425640 e.g. 5-(2-benzyloxy-cyclohexylcarbamoyl)-1-[(2-benzyloxy-cyclohexylcarbamoyl)-methyl]-1H-pyrazole-3-carboxylic acid ethyl ester; inhibiting hepatitis C virus (HCV) RNA-dependent RNA polymerase; HIV infection, AIDS; with additional antiviral agent as ribavirin and alpha -interferon or pegylated interferon |
| 09/16/2008 | US7425630 Processes for preparing pyrazolo[3,4-d]pyrimidine ethers |
| 09/16/2008 | US7425572 and elevated intraocular pressure; e.g. 2-(7,8-Dihydro-[1,4]dioxino[2,3-g]indazol-1-yl)-1-methyl-ethylamine; serotonin 5-HT2 receptor agonists; chemical stability, sustained release |
| 09/16/2008 | US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 09/12/2008 | WO2008109697A2 Ppar active compounds |
| 09/12/2008 | WO2008109027A2 Tri-aryl/heteroaroaromatic cannabinoids and use thereof |
| 09/12/2008 | WO2008108407A1 Metal complex, light-emitting device and display |
| 09/12/2008 | WO2008107455A1 Indazoles used to treat estrogen receptor beta mediated disorders |
| 09/12/2008 | WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/12/2008 | WO2008053044A3 Hetaryl carbon acid-n-(biphen-2-yl)amide compounds |
| 09/12/2008 | WO2008012227A8 Pyrazoles as glucokinase activators |
| 09/12/2008 | WO2004078116A9 P38 inhibitors and methods of use thereof |
| 09/12/2008 | CA2680109A1 Indazoles used to treat estrogen receptor beta mediated disorders |
| 09/12/2008 | CA2679844A1 Ppar active compounds |
| 09/11/2008 | US20080221127 Ppar active compounds |
| 09/10/2008 | EP1966152A2 Glucokinase activators |
| 09/10/2008 | EP1966151A1 Polycyclic indazole derivatives that are erk inhibitors |
| 09/10/2008 | EP1966150A1 Pyrazoles for the treatment of gerd and ibs |
| 09/10/2008 | EP1966149A1 Biphenyl carboxamides for controlling micro-organisms |
| 09/10/2008 | EP1966148A1 Carboxamides |
| 09/10/2008 | EP1966147A1 Carboxamides for controlling micro-organisms in plant and material protection |
| 09/10/2008 | EP1966146A1 4,5-dihydro- (1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators |